Sales increased by 29% compared to first half 2022Number of BIOCERA-VET units distributed1 increased by 31% compared to the first half of 2022, taking into account the successful introduction of BIOCERA-VET 3 1ccAcceleration of sales growth over the summer months of 2023 with more than 250% increase in BIOCERA-VET u.
GOSSELIES, Belgium, July 11, 2023 Regulatory News: TheraVet (ISIN: BE0974387194 - ticker: ALVET) (Paris:ALVET) (Brussels:ALVET), a pioneering company in the management of osteoarticular diseases in companion animals, provides the half-year update on its development strategy.
TheraVet Announces 300% Increase in Participating Centers in the Osteosarcoma Program Since Its Initiation 6 Months Ago finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Fast-growing interest in Osteosarcoma Program since official launch end- March 2023 with a 33% increase in participating Centers16 participating Centers in 7 countriesSuccessful participation to the congress of the European Society of Veterinary OncologyGOSSELIES, Belgium (BUSINESS WIRE) Regulatory News:TheraVet (.
BIOCERA-VET COMBO-CLEAN, a unique bone substitute for antibiotic delivery: combinable with all main antibiotics covering the usual germs involved in bone infections, providing